AstraZeneca Tagrisso with chemotherapy approved in US for EGFR-mutated advanced lung cancer Ruchika Sharma17 Feb 2024 12:00 PM ISTTagrisso (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against CNS metastases.
AstraZeneca, BioInvent ink pact to evaluate BI-1206 in combo with rituximab, Calquence Ruchika Sharma12 Feb 2024 4:30 PM ISTSweden: BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory...
AstraZeneca-Ionis Eplontersen granted USFDA fast track designation for transthyretin-mediated amyloid cardiomyopathy Ruchika Sharma10 Feb 2024 3:30 PM ISTCarlsbad: Ionis Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Ionis...
AstraZeneca Enhertu granted priority review in US for metastatic HER2-positive solid tumours Ruchika Sharma31 Jan 2024 12:45 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been...
AstraZeneca bags CDSCO nod to import, market Andexanet Alfa in India Ruchika Sharma23 Jan 2024 4:45 PM ISTBangalore: AstraZeneca Pharma India Ltd., has announced that it has received approval from Central Drugs Standard Control Organisation (CDSCO) in...
AstraZeneca Voydeya approved in Japan for paroxysmal nocturnal haemoglobinuria Ruchika Sharma21 Jan 2024 12:30 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal...
AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China Ruchika Sharma2 Jan 2024 3:06 PM ISTChina: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...
AstraZeneca to buy Gracell Biotechnologies for USD 1.2 billion Ruchika Sharma27 Dec 2023 10:00 AM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical...
AstraZeneca Gets CDSCO Panel Nod for Enhertu 100mg for additional indication of breast cancer Dr. Divya Colin25 Dec 2023 6:00 PM ISTNew Delhi: Noting an unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Wainua gets USFDA nod for adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis Ruchika Sharma24 Dec 2023 2:45 PM ISTUS: AstraZeneca and Ionis' Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary...
COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol Ruchika Sharma15 Dec 2023 4:30 PM ISTBangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO)...
AstraZeneca gets CDSCO panel Nod to study anti-cancer drug Volrustomig in women with cervical cancer Dr. Divya Colin14 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
